abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)

abrdn Life Sciences Investors Shares of Beneficial Interest (HQL $17.65)
- $17.65 Cap: $451M
- View HQL Profile
- View Questions on HQL

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

abrdn Life Sciences Investors Shares of Beneficial Interest (HQL $17.65)
- $17.65 Cap: $451M
- View HQL Profile
- View Questions on HQL

Q: TEKLA LIFE SCIENCE - Hello Peter, I am underweight in HeALTHCARE and thinking of HQL. Has good distribution. Would you endorse it or suggest an alternative. thanks

Read Answer Asked by RUPINDER on December 07, 2017